GC
NVRO

Grace Capital’s NEVRO CORP. NVRO Stock Holding History

Grace Capital’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,263
Closed -$420K – 226
2018
Q2 		$420K Sell
5,263
-6,014
-53% -$499K 0.16% 122
2018
Q1 		$980K Sell
11,277
-10,672
-49% -$862K 0.52% 56
2017
Q4 		$1.51M Buy
21,949
+7,538
+52% +$603K 0.53% 55
2017
Q3 		$1.31M Buy
+14,411
New +$1.23M 0.48% 65

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Grace Capital's NVRO Position: Q3 2018 in Review

Grace Capital sold out of NEVRO CORP. (NVRO) in Q3 2018, closing a stake of 5,263 shares — an estimated $420K sold.

Grace Capital first reported a position in NVRO in Q3 2017 and held it in 4 quarters. The position peaked at $1.51M in Q4 2017. 171 funds tracked by Wall St. Rank hold NVRO as of Q3 2018.

  • Grace Capital reported no remaining NEVRO CORP. position as of Q3 2018 after selling out during the quarter.
  • Grace Capital sold 5,263 NEVRO CORP. shares in Q3 2018, an estimated $420K.
  • Grace Capital first reported a position in NEVRO CORP. in Q3 2017 and held it in 4 quarters.
  • Grace Capital's NEVRO CORP. position peaked at $1.51M in Q4 2017.
  • 171 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2018.

Based on Grace Capital's 13F filing for Q3 2018, filed 14 Nov 2018.